APA (7th ed.) Citation

Creed, T. J., Norman, M. R., Probert, C. S. J., Harvey, R. F., Shaw, I. S., Smithson, J., . . . Hearing, S. D. (2003). Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. Alimentary Pharmacology & Therapeutics, 18(1), 65. https://doi.org/10.1046/j.1365-2036.2003.01639.x

Chicago Style (17th ed.) Citation

Creed, T. J., et al. "Basiliximab (anti-CD25) in Combination with Steroids May Be an Effective New Treatment for Steroid-resistant Ulcerative Colitis." Alimentary Pharmacology & Therapeutics 18, no. 1 (2003): 65. https://doi.org/10.1046/j.1365-2036.2003.01639.x.

MLA (9th ed.) Citation

Creed, T. J., et al. "Basiliximab (anti-CD25) in Combination with Steroids May Be an Effective New Treatment for Steroid-resistant Ulcerative Colitis." Alimentary Pharmacology & Therapeutics, vol. 18, no. 1, 2003, p. 65, https://doi.org/10.1046/j.1365-2036.2003.01639.x.